Navigation Links
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Date:9/13/2011

le metabolic effects in healthy subjects, together with the safety profile observed to date, suggest that LX4211 could be considered earlier in the diabetes treatment paradigm, perhaps including the potential treatment of pre-diabetes in patients with impaired glucose tolerance or impaired fasting glucose (IGT/IFG)."

About the Clinical Trial

The clinical trial was designed to assess the effect of different LX4211 dose schedules relative to meal time  in healthy subjects when taken as a single daily dose (400 mg) or a split dose (200 mg twice daily).  Subjects were randomized to LX4211 in an ordered sequence to assess the pharmacodynamic effects of different dosing times, ranging from 1 hour prior to meals to immediately prior to meals.  Pharmacodynamic effects, include urinary glucose excretion, fasting plasma glucose, insulin, PYY and GLP-1 (total and active) were assessed at multiple time points during the 12-day dosing period.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX4211, including characterizations of the results of and projected timing o
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
2. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
3. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
4. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014  RT Oncology Services Corporation today announced that ... board of directors. Mr. Mundie is currently senior advisor ... on strategic projects within the company and on technology ... and strategy officer. Mike Martin ... "Craig is a visionary technology executive. His appointment is ...
(Date:7/23/2014)... BOHEMIA, N.Y. , July 23, 2014 /PRNewswire-iReach/ -- Top ... of GPM Pediatrics offers his feedback on article, which discusses ... Photo - http://photos.prnewswire.com/prnh/20140722/129440 According to ... of accidental injury and death among American children aged 1 ... inches of water." One expert in the article ...
(Date:7/23/2014)... , July 23, 2014  Mezzion Pharma Co. Ltd., ... evaluate the use of udenafil to treat adolescents who ... heart defects. The clinical program will follow protocols developed ... Pediatric Heart Network (PHN), a multi-center clinical research network ... (NHLBI) of the National Institutes of Health (NIH). ...
Breaking Medicine Technology:Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2
... Medical, Inc. (OTCBB: AEMD) announced today that its wholly ... ability of its Enzyme Linked Lectin Specific Assay (ELLSA) ... immunodeficiency virus (HIV), tuberculosis (TB), and various forms of ... July 2010, ESI disclosed that it filed a patent ...
... WARSAW, Ind., April 12, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
Cached Medicine Technology:Aethlon Medical Announces Multi-Target Exosome Assay Validation 2Aethlon Medical Announces Multi-Target Exosome Assay Validation 3Aethlon Medical Announces Multi-Target Exosome Assay Validation 4Aethlon Medical Announces Multi-Target Exosome Assay Validation 5Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2011 Results 2
(Date:7/24/2014)... “To care for him who shall have borne the ... quote is attributed to Abraham Lincoln. It is also the ... yet the reality of Lincoln’s words, and admonition to care ... in times of conflict, leaves much to be desired, according ... a battle they never expected to wage: the battle for ...
(Date:7/24/2014)... July 24, 2014 The Republic of Tea, ... new CARDAMOM CRÈME BRÛLÉE TEA to celebrate “The Hundred-Foot Journey,” ... Winfrey and Juliet Blake. A hundred-foot journey begins in the ... over into a new realm that is far out of ... in physical distance that materially changes the course of your ...
(Date:7/24/2014)... Crawford Technologies today announced the ... with AIIM, focusing on global trends in high-volume ... the survey indicated that even though organizations stated ... customer service, legal and regulatory compliance and historical ... exact facsimiles of these documents. , The survey ...
(Date:7/24/2014)... Parsippany, NJ (PRWEB) July 24, 2014 Losing ... emotions – overwhelming sadness as well as shock, fear, guilt, ... a spouse's death agonizing and confusing. It may be small ... be temporary but it is in fact the case that ... entirely,” says clinical psychologist Dr. Hayley Hirschmann of ...
(Date:7/24/2014)... Professional Healthcare at Home, an affiliate of Kindred at ... with the company’s Pleasant Hill, CA, home health care agency, ... Home Care & Hospice Nurse of the Year Award presented ... , Annually, NAHC promotes a nationwide recognition campaign that ... a top home care and hospice nurse from every state. ...
Breaking Medicine News(10 mins):Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 3Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 4Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 5Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 2Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 2Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 4Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 2Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 3
... Neurological ailments varying from migraines to Alzheimer's disease affect ... reported// by WHO in ‘Neurological disorders: Public health challenges’. ... are affected by disease like Alzheimer's and other dementias ... far-reaching care. These issues are compounded when there ...
... Smithkline has been filed for approval with America’s FDA and ... by March 13 and by September in US and Europe ... is expected to generate ? 1 bn a year not ... kidney carcinomas. Navid Malik, an analyst from Collins Stewart states ...
... poll by an online website Netmums, has the outcome that ... be simple and understandable//, especially when in a hurry while ... persons interviewed supported the ‘traffic lights’ system of labeling over ... companies. ,In the former system, akin to traffic ...
... autoimmune disease, have a high risk of death from ... general population, studies overwhelmingly show. Evidence has been less ... dying from cancer. ,The first study to ... a decreased rate of survival, featured in the issue ...
... Technologies (ARTs) do not increase the risk of genetic ... mice will be released in this week’s journal, Proceedings ... there have now been more than 3 million humans ... very few studies of potential genetic abnormalities resulting from ...
... the relationship between use of antidepressants and level ... the link between depression and level of alcohol ... Addiction and Mental Health (CAMH) concluded that women ... who did not experience depression, regardless of antidepressant ...
Cached Medicine News:Health News:Mothers Gives ‘thumbs Up’ for Traffic Light Labeli 2Health News:The Link Between Rheumatoid Arthritis and Cancer 2Health News:Researchers Study Safety of Assisted Reproductive Technologies 2Health News:Antidepressants Help Men Decrease Alcohol Consumption, but Not Women 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: